CRISPR

CRISPR1-mcoln1b

ID
ZDB-CRISPR-171023-1
Name
CRISPR1-mcoln1b
Previous Names
None
Target
Sequence
5' - GGCTCCGGGGACCTGAACGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hg84 mcoln1b
hg85 mcoln1b
Expression
Gene expression in Wild Types + CRISPR1-mcoln1b
No data available
Phenotype
Phenotype resulting from CRISPR1-mcoln1b
No data available
Phenotype of all Fish created by or utilizing CRISPR1-mcoln1b
Phenotype Fish Conditions Figures
retina apoptotic process increased occurrence, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 5 from Li et al., 2017
whole organism decreased life span, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 1 from Li et al., 2017
neuromast hair cell mitochondrion broken, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. S8 from Li et al., 2017
retina homeostasis disrupted, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 5 from Li et al., 2017
brain apoptotic process increased occurrence, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 6 from Li et al., 2017
retina apoptotic body increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 5 from Li et al., 2017
neuromast hair cell vacuole increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 8 from Li et al., 2017
skeletal muscle cell microtubule cytoskeleton disorganized, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. S1 from Li et al., 2017
neuromast disorganized, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 8 from Li et al., 2017
cornea glycosaminoglycan increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. S5 from Li et al., 2017
skeletal muscle ab4-map1lc3 labeling increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 2 from Li et al., 2017
neuromast hair cell kinocilium decreased length, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 10 from Li et al., 2017
skeletal muscle cell lysosome increased size, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 3Fig. 4 from Li et al., 2017
retinal outer nuclear layer decreased thickness, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 5 from Li et al., 2017
skeletal muscle cell mitochondrion morphology, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 4Fig. S1 from Li et al., 2017
neuromast hair cell nucleus irregularly shaped, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 8 from Li et al., 2017
retinal inner nuclear layer cell decreased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 5 from Li et al., 2017
neuromast hair cell kinocilium decreased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 10 from Li et al., 2017
neuromast hair cell autolysosome increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 9 from Li et al., 2017
neuromast hair cell autophagy disrupted, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 9 from Li et al., 2017
skeletal muscle cell microtubule shortened, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. S1 from Li et al., 2017
neuromast neuromast hair cell position, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 chemical treatment by environment: neomycin Fig. 8 from Li et al., 2017
skeletal muscle cell ab4-map1lc3 labeling increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 2 from Li et al., 2017
neuromast hair cell decreased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 7 from Li et al., 2017
skeletal muscle cell neuromuscular junction morphology, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 3 from Li et al., 2017
skeletal muscle autophagy disrupted, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 4 from Li et al., 2017
skeletal muscle cell autophagosome increased amount, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 2Fig. 4 from Li et al., 2017
skeletal muscle cell autophagosome aggregated, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 2 from Li et al., 2017
eye apoptotic process increased occurrence, abnormal mcoln1bhg84/hg84; mcoln1ahg82/hg82 standard conditions Fig. 6 from Li et al., 2017
Citations